TABLE 2.
LG (n = 415) mean (SD) | MG (n = 1,043) mean (SD) | HG (n = 569) mean (SD) | P | Post-hoc | |
Age (years) | 45.3 (15.3) | 46.5 (15.4) | 44.5 (14.7) | 0.032a | |
Gender (% Female) | 55.7% | 53.3% | 55.5% | 0.59b | |
CPZeq (mg/day) | 599.9 (391.8) | 689.5 (442.4) | 733.5 (490.6) | 1.9 × 10–15a | LG < MG = HG |
Antipsychotic monotherapy (%) | 70.8% | 53.3% | 49.9% | 1.3 × 10–11b | LG < MG = HG |
Benzodiazepines(%) | 53.7% | 71.2% | 71.5% | 1.8 × 10–10b | LG < MG < HG |
Antidepressant (%) | 7.5% | 8.9% | 8.4% | 0.67b | |
Mood stabilizer (%) | 31.6% | 37.6% | 34.8% | 0.087b |
One-way analysis of variance (ANOVA) and Fischer’s exact test were used to make comparisons among the LG, MG, and HG with post-hoc Bonferroni.
CPZ-eq, chlorpromazine equivalent; LG, low rate group; MG, medium rate group; HG, high rate group.
aReports F-value.
bReports χ2-statistic.